All News #Library
Rare Diseases
OS Therapies Seeks RMAT Designation for OST-HER2 in Lung Metastat
06 Jun 2025 //
BUSINESSWIRE
OS Therapies Reports Positive Data For OST-HER2 In Breast Cancer
24 Jul 2024 //
BUSINESSWIRE

Market Place
Sourcing Support